Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer

NCT03937895 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

BIOLOGICAL: 'SMT-NK' Inj (allogeneic Natural Killer cell)
DRUG: Pembrolizumab Injection [Keytruda]

Sponsor

SMT bio Co., Ltd.